Monoclonal Mouse anti‑Human Apolipoprotein A‑V Antibody (clone 2G1H11, IHC, IF, WB) LS‑C41368
Monoclonal Mouse anti‑Human Apolipoprotein A‑V Antibody (clone 2G1H11, IHC, IF, WB) LS‑C41368
Antibody:
Apolipoprotein A-V Mouse anti-Human Monoclonal (2G1H11) Antibody
Application:
IHC, IHC-P, IF, WB, ELISA
Format:
Unconjugated, Unmodified
Overview
Antibody:
Apolipoprotein A-V Mouse anti-Human Monoclonal (2G1H11) Antibody
Application:
IHC, IHC-P, IF, WB, ELISA
Format:
Unconjugated, Unmodified
Specifications
Description
Apolipoprotein A-V antibody LS-C41368 is an unconjugated mouse monoclonal antibody to human Apolipoprotein A-V. Validated for ELISA, IF, IHC and WB.
Target
Human Apolipoprotein A-V
Synonyms
APOA5 | Apo-AV | APOAV | Apolipoprotein A5 | Apo-A5 | Apolipoprotein A-V | RAP3 | ApoA-V
Reactivity
Human
(tested or 100% immunogen sequence identity)
Clonality
IgG1
Monoclonal
Conjugations
Unconjugated
Immunogen
Purified recombinant fragment of human Apoa5 expressed in E. Coli.
Applications
- IHC
- IHC - Paraffin
- Immunofluorescence (1:200 - 1:1000)
- Western blot (1:100 - 1:500)
- ELISA (1:10000)
|
Performing IHC? See our complete line of Immunohistochemistry Reagents including antigen retrieval solutions, blocking agents
ABC Detection Kits and polymers, biotinylated secondary antibodies, substrates and more.
|
Presentation
Ascitic fluid, 0.03% sodium azide
Storage
Short term: store at 4°C. Long term: store at -20°C.
Restrictions
For research use only. Intended for use by laboratory professionals.
Guarantee
This antibody carries the LSBio 100% Guarantee.
LSBio Guarantee
Featured Products
Species:
Human, Mouse, Rat
Applications:
Western blot, ELISA
Species:
Mouse
Applications:
Western blot
Species:
Human, Monkey, Mouse
Applications:
Western blot
Reactivity:
Mouse
Range:
0.312-20 ng/ml
Reactivity:
Human
Range:
0.78-50 ng/ml
Reactivity:
Human
Range:
1.25-80 ng/ml
Request SDS/MSDS
To request an SDS/MSDS form for this product, please contact our Technical Support department at:
Technical.Support@LSBio.com
Requested From: United States
Date Requested: 12/25/2024